levofloxacin

Metabolite details

Identifier

GSDSWSVVBLHKDQ-JTQLQIEISA-N

InChI Key

GSDSWSVVBLHKDQ-JTQLQIEISA-N

IUPAC name

(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

Preferred name

levofloxacin

INN name

levofloxacinum

Synonym

(-)-Ofloxacin

ChEBI

CHEBI:63598

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Brain metabolomic profiling of eastern honey bee (Apis cerana) infested with the mite Varroa destructor.
• Disturbed Microbiota-Metabolites-Immune Interaction Network is Associated with Olfactory Dysfunction in Patients with Chronic Rhinosinusitis

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Control_vs_Lithogenic_Diet
• Mite_Infestation_vs_Control
• Mite_Infestation_vs_Control
• Normal_vs_Abnormal